Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Xeris Biopharma Holdings Inc. buy SVB Leerink LLC

Xeris Biopharma Holdings Inc.
Start price
€6.61
22.08.25 / 50%
Target price
€7.75
22.08.26
Performance (%)
9.80%
Price
€7.26
15:20
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC shows slight gains of 9.80%. This prediction currently runs until 22.08.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Xeris Biopharma Holdings Inc. 7.420% 7.420%
iShares Core DAX® -0,05 % 5,96 %
iShares Nasdaq 100 0,92 % 3,69 %
iShares Nikkei 225® 3,01 % 6,64 %
iShares S&P 500 -0,36 % 2,75 %

Comments by SVB_Leerink_LLC for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 9.80%
Target price 7.754
Change
Ends at 22.08.26

Xeris Biopharma (NASDAQ:XERS) had its price target raised by analysts at Leerink Partners from $7.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat

SVB Leerink LLC 
0
Report Share
22.08.25

Stopped prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.

buy
Xeris Biopharma Holdings Inc.

Start price
Target price
Perf. (%)
€4.21
10.03.25
€5.52
10.03.26
17.02%
11.03.26

SVB Leerink LLC 
10.03.25 50%